CAS: 36504-94-6 - Butaclamol hydrochloride
Formula:C25H31NO·ClH
InChI:InChI=1/C25H31NO.ClH/c1-24(2,3)25(27)13-14-26-16-21-19-9-5-4-7-17(19)11-12-18-8-6-10-20(23(18)21)22(26)15-25;/h4-10,21-22,27H,11-16H2,1-3H3;1H/t21-,22-,25-;/s2
InChI key:InChIKey=QZRUMKUMFJJARD-MACWAGGUNA-N
SMILES:Cl.OC1(CCN2CC3C=4C=CC=CC4CCC5=CC=CC(=C53)C2C1)C(C)(C)C
- Synonyms:
- (3S,4aS,13bS)-3-tert-butyl-2,3,4,4a,8,9,13b,14-octahydro-1H-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol
- 1H-Benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol, 3-(1,1-dimethylethyl)-2,3,4,4a,8,9,13b,14-octahydro-, hydrochloride (1:1), (3R,4aR,13bR)-rel-
- 1H-Benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol, 3-(1,1-dimethylethyl)-2,3,4,4a,8,9,13b,14-octahydro-, hydrochloride, (3R,4aR,13bR)-rel-
- 1H-Benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol, 3-(1,1-dimethylethyl)-2,3,4,4a,8,9,13b,14-octahydro-, hydrochloride, (3α,4aα,13bβ)-
- Ay 23038
- Ay-23028
- Butaclamol hydrochloride
- [4a,13b-trans][3(OH),13b(H)-trans]-3-tert-butyl-2,3,4,4a,8,9,13b,14-octahydro-1H-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol hydrochloride
- dl-Butaclamol hydrochloride
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
(+/-)-Butaclamol Hydrochloride REF: TR-B694300CAS: 36504-94-6 | - - - | 13,346.00 € | Tue 18 Feb 25 | |
Butaclamol HCl REF: TM-T69355CAS: 36504-94-6 | - - - | 1,386.00 €~2,279.00 € | Wed 26 Feb 25 |
(+/-)-Butaclamol Hydrochloride
Controlled ProductCAS:36504-94-6
Formula:
C25H31NO·ClH
Color and Shape:
Neat
Molecular weight:
397.981
Ref: TR-B694300
500mg | 13,346.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Butaclamol HCl
CAS:36504-94-6
Butaclamol (AY-23,028), an unmarketed typical antipsychotic, is a research chemical that inhibits dopamine receptors.
Formula:
C25H32ClNO
Color and Shape:
Liquid
Molecular weight:
397.98
Ref: TM-T69355
25mg | 1,386.00 € | ||
50mg | 1,805.00 € | ||
100mg | 2,279.00 € |
Estimated delivery in United States, on Wednesday 26 Feb 2025